The Dahlem Format Deserves Imitation

A conference at which no one reads a single paper may seem a contradiction in terms. In fact, Dahlem Konferenzen, which this month reach 50 in their unique series of highly successful gatherings in West Berlin, are of exactly that sort. Dahlem conferences generate their prestigious state-of-the-art reports through a sensitively structured five-day program of group discussions and feedback. They contrast starkly with the type of congress at which fragments of worth are lost among a phalanx of pre

Written byFauzi Mantoura
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Perhaps the reason is finance—met in Berlin by the City's Senate, the Stifterver-band fur die Deutsche Wissenschaft (a foundation supported by German trade and industry), and the Deutsche For-schunsgemeinschaft (the German Science Foundation). Add up the costs of planning meetings by an international program advisory committee of eight to 10 scientists, travel and stylish accommodations for 40 participants, plus such delights as a concert by the Berlin Philharmonic Orchestra, and it's clear that Dahlem Konferenzen are not cheap.

But while richly enjoyable, these are not occasions for leisurely contemplation. Their prime mover, Silke Bernhard, has evolved a structure that wou1d make it very difficult for participants not to pull their weight. Dahlem topics are divided into four subthemes, aspects of which are reviewed initially in papers prepared by group members. All participants receive these papers before setting off for Berlin, their comments and questions being circulated during the conference. After ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies